The California Newborn Screening Program 2024 New NBS Disorders webinar was held on June 13, 2024 at 10:30 AM. This webinar includes important updates regarding the Newborn Screening Program testing panel expansion to include Mucopolysaccharidosis type II (MPS II) and Guanidinoacetate methyltransferase deficiency (GAMT). Essential topics were covered on these new disorders such as screening algorithms, clinical presentation and treatment options, updates to our SIS system, and resources from advocacy groups for families. Speakers include: Tracey Bishop, Genetic Disease Screening Program (GDSP) Paul Harmatz, MD, University of California, San Francisco, Terri Klein, National MPS Society Nicola Longo, MD PhD, University of California, Los Angeles, Kim Tuminello, Association for Creatine Deficiencies, Rajesh Sharma, PhD, Genetic Disease Laboratory (GDSP) If you need additional information, or are having difficulty accessing this content, please contact [email protected] to request this information in an alternate format

If you need additional information, or are having difficulty accessing this content, please contact [email protected] to request this information in an alternate format.